For the temporary relief of mild to moderate arthritic pain, osteoarthritis and, joint stiffness.
Pharmacological and clinical notes; Constituents Indications:
Arthrosis deformans, coxitis, periarthritis humero-scapularis.
Funiculus umbilicalis (Wharton's jelly, (umbilical cord)
Damage to connective tissues, circulatory disorders.
For revitalization in the cellular phases.
Circulatory disturbances, pernios.
Rhus toxicodendron (poison ivy)
Rheumatism and neuralgia, worse in cold, wet weather; polyarthritis, diseases of the mucosa and connective tissues.
Arnica (mountain arnica)
To stimulate the healing of wounds, rheumatism, injuries arising from falls, blows or contusions; pains in the back and limbs.
Remedy to counteract the effects of wet weather sensation of having caught a chill, rheumatic disorders.
Injuries to the tendons, ligaments and periosteum; acts on the joints in general, neuralgia of the knee.
Neuralgic and rheumatoid pains of the joints and muscles.
Reagent in all chronic diseases; cellular activity is influenced catalytically.
Silicea (sillicic acid)
Weakness and impairment of the connective tissues; weakness of the ligaments.
Nadide (nicotinamide adenine dinucleotide)
Coenzyme, stimulation of the end oxidation in the respiratory chain.
Coenzyme A (Coenzyme A)
Coenzyme for transacetylation.
Coenzyme in the decomposition of pyruvic acid.
Active factor of the citric acid cycle and of redox systems; sensitivity to damp and wind.
For the maintenance of normal articular functions, undisturbed co-ordination of the metabolism of the synovial membrane and synovial fluid on the one hand and of the arthrodial cartilage on the other, is indispensable.
In the cartilage, according to the Embden-Meyerhof model, lactic acid or lactate is formed, which reaches the outer cellular layer of the joint capsule through the synovial fluid. There, by stimulation of the end oxidation through the citric acid cycle, the necessary energy is released. In arthrosis, there is a pathological alteration of the metabolism of the connective tissue in the joint (cartilage, synovial membrane and also synovial fluid), characterized by increased degradation of the connective tissue structures. This results, therefore, in disproportion between catabolic and anabolic metabolic processes.
The task of effective therapy is to normalize the disturbed metabolism, as well as offering components for possible incorporation.
The decisive energy-liberating reaction of the metabolism is the formation of hydrogen, which is then transferred, to a great extent, to nicotinamide adenine dinucleotide (nadid); thus, for example, the whole of the hydrogen liberated in the course of the citric acid cycle is transferred to nadid, the starting member of the respiratory chain. Precisely the oxidoreduction, catalysed by nadid, between lactic acid and pyruvic acid, or the reverse, is of decisive importance in the metabolism of the joints.
Thioctic acid is also a hydrogen-transferring co-factor which, above all, participates decisively in the oxidative decarboxylation (conversion of pyruvic acid to "activated acetic acid").
In the interaction with coenzyme A, the formation of the "activated acetic acid") is made possible which, for its part, represents the "initiator" of the citric acid cycle, while oxalacetate can be described as the fuel, or also as the engine,of the citric acid cycle.
The treatment of rheumatic diseases with sulphur has long been known. It is only through the biochemical research into mucopolysaccharide sulphates, however, that it was confirmed, i.e. could be established, that the organism can incorporate or convert the sulphur into chondroitin sulphates intrinsic to the body.
The organ constituents provide important components of the connective tissue (cartilage, funiculus umbilicalis), while placenta promotes the circulation and the embryo has an additional stimulating action.
The botanical constituents from Rhus toxicodendron, Dulcamara, Sanguinaria, Symphytum and Arnica are applied for rheumatic diseases of the joints, etc., including when the disorders are worsened in wet weather.
The medicaments blended into a pharmacologically active and non-toxic combination in Zeel, on the basis of many years' medical experience and the most recent biochemical research form a highly valuable remedy for chronic diseases of the joints, as can be seen from the composition and from what has been confirmed by clinical and practical tests.
Based on the individual homeopathic constituents of Zeel, therapeutic possiblities result for the treatment of arthrosis (in particular gonarthrosis), polyarthrosis, spondylarthrosis, periarthritis humeroscapularis.
These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.